Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.85
NaN%
Comments
Loading...
Sinovac Biotech Analyst Ratings and Price Targets | NASDAQ:SVA | Benzinga
Sinovac Biotech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Sinovac Biotech Corp from these most-recent analyst ratings.
Analyst Ratings for Sinovac Biotech
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Sinovac Biotech (SVA) stock?
There is no price target for Sinovac Biotech
What is the most recent analyst rating for Sinovac Biotech (SVA)?
There is no analyst for Sinovac Biotech
When was the last upgrade for Sinovac Biotech (SVA)?
There is no last upgrade for Sinovac Biotech
When was the last downgrade for Sinovac Biotech (SVA)?
There is no last downgrade for Sinovac Biotech.
When is the next analyst rating going to be posted or updated for Sinovac Biotech (SVA)?
There is no next analyst rating for Sinovac Biotech.
Is the Analyst Rating Sinovac Biotech (SVA) correct?
There is no next analyst rating for Sinovac Biotech.
Browse analyst ratings and price targets on all stocks.